Nektar Therapeutics (NKTR) Tops Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Nektar Therapeutics (NKTR) PT Lowered to $86 at Cowen
August 9, 2018 7:41 AM EDTCowen lowered its price target on Nektar Therapeutics (NASDAQ: NKTR) to $86.00 (from $101.00) while maintaining a Outperform rating.
... More